University Hospitals Birmingham NHS Foundation Trust (UHB) is recognised as one of the leading hospitals in the UK and has an international reputation for quality of care, informatics/IT, clinical training and research. UHB provides direct clinical services to 700,000 patients every year, serving a regional, national and international population.
UHB has an annual turnover of £584 million and employs over 7,200 staff. It has successfully transferred its services from two hospitals, a mile and a half apart, into the UK’s newest and largest single site hospital. The £545 million Queen Elizabeth Hospital Birmingham opened its doors to patients in 2010 and has 1,213 in-patient beds, 32 operating theatres and a 100-bed critical care unit.
The Trust is a regional centre for cancer, trauma, burns and plastics and organ transplantation. UHB is host to the Royal Centre for Defence Medicine (RCDM) and treats all seriously injured British military personnel evacuated from overseas.
UHB has developed bespoke in-house electronic systems to improve the provision of information to patients and enable shared decision-making, for example, via the [email protected] system, which is anticipated to be used by 2,000 patients by July 2013. Significant progress in the digitisation of patients’ medical records is enabling real-time access to, and analysis of, clinical data, with the Outpatients Department now working on a largely paperless basis.
UHB hosts the National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC) and became one of the UK’s 22 Major Trauma Centres in March 2012. The SRMRC has established three major research strands (Regenerative and Reconstructive Medicine, Microbiology, Acute Response to Injury) that will see benefits for military and civilian trauma victims.
The UHB/University of Birmingham (UoB) campus is home to the first Cancer Research UK Centre which makes Birmingham one of the largest centres for clinical trials in the UK. Also in partnership with UoB, UHB hosts the Birmingham NIHR Liver Biomedical Research Unit (BRU), part of a multi-million pound scheme to prevent, diagnose and treat ill-health funded by the NIHR. It focuses on translational research and allows a team of scientists to undertake challenging and complex translational research to develop new therapies for liver disease.
UHB is the lead NHS partner Trust within the NIHR CLAHRC-BBC (Collaborations for Leadership in Applied Health Research and Care for Birmingham and the Black Country). This programme undertakes high-quality applied health research focused on the needs of patients, the results of which can be put into practice in the NHS.
UHB is part of the West Midlands Central Health Innovation and Education Cluster (HIEC), a partnership between NHS organisations, the higher education sector, industry and other public and private sector organisations. Through this collaboration the Trust enables high quality patient care and services by quickly realising the benefits of research and innovation, and strengthening the co-ordination of education to support excellence. A new collaboration called Birmingham Health Partners (BHP) was launched in January 2012 to capture the wealth of clinical and academic expertise within UHB and the co-located University of Birmingham.
The Trust was awarded in the region of £21.6 million in research income in 2011/12.
Chief Executive: Dame Julie Moore
Dame Julie Moore is a graduate nurse who worked in clinical practice before moving into management. She was appointed Executive Director of Operations at University Hospital Birmingham in 2002 and subsequently became Chief Executive in 2006.
Dame Julie was a member of the National Organ Donation Taskforces in 2007 and 2008. In 2009 she was a member of the Nuffield Trust Steering Group on New Frontiers in Efficiency.
She is a member of the International Advisory Board of the University of Birmingham Business School, an Independent board member of the Office for Strategic Co-ordination of Health Research (OSCHR) and a member of the MoD/DH Partnership Board overseeing health care of military personnel.
Dame Julie is also a member of the Commission on Living Standards undertaken by the Resolution Foundation and a board member of Marketing Birmingham, a strategic partnership to drive the inward investment strategy for the city. She is also a Fellow of the Royal Society of Arts. She was knighted in the 2011 New Year Honours list.